23andMe
Shed Enters Genetic Testing With At-Home Fitness & Wellness Kits
Shed launches at-home DNA kits to personalize fitness, nutrition and wellness, with tests offering insights on diet, exercise and recovery.
$305M Power Play: Anne Wojcicki Outbids Regeneron for 23andMe
Anne Wojcicki has outbid Regeneron with a $305 million offer to reclaim 23andMe, the genetic health tech company she co-founded.
23andMe Finds $256M Buyer in Regeneron After Chapter 11 Filing
Regeneron is acquiring 23andMe’s core assets for $256 million following the genetic testing company’s Chapter 11 filing.
From Founder to Bidder: 23andMe CEO Resigns As Genetics Company Files for Bankruptcy
23andMe's co-founder and CEO has resigned, positioning herself as a bidder for the company that has just filed for bankruptcy.
What’s Defining Wellness in 2025? Here’s What 5 Experts Say
Athletech News spoke with several leading health experts to uncover what’s driving the future of wellness in 2025.
23andMe Lays Off 40% of Staff, Dissolves Therapeutics Division
23andMe, once a biotech unicorn, is struggling to stay afloat, marred by several challenges, including the swift resignation of its board.
CrossFit & 23andMe Leading New Wave in Telemedicine
CrossFit & 23andMe are hedging their hefty bets, with the latter signing a $400 million deal with Lemonaid Health.
